CAR Therapy Research Heats Up – Clinical Oncology News
Clinical Oncology News |
CAR Therapy Research Heats Up
Clinical Oncology News Boston—While checkpoint inhibitors may be stealing the cancer news spotlight these days, advances in chimeric antigen receptor–modified T–cell therapy (CAR therapy) also have immuno-oncology investigators excited. “Hopefully, we will see approvals for … Nanoparticles reprogram immune cells to fight cancer Fred Hutch study: New nanoparticle immunotherapy could replace chemo as front-line cancer treatment Nanoparticles To Fight Cancer? Immune System Can Be Reprogrammed With Them, Researchers Say |
